Nakaoka Y, Isobe M, Takei S, et al: Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in japan (the TAKT study). Ann Rheum Dis 2018; 77: 349-354.
Villiger PM, Adler S, Kuchen S, et al: Tocilizumab for induction and maintenance of remission in giant cell arteritis: A phase 2, randomised, double-blind, placebo-controlled trial. Lancet 2016; 387: 1921-1927.
Stone JH, Tuckwell K, Dimonaco S, et al: Trial of tocilizumab in giant-cell arteritis. N Engl J Med 2017; 377: 317-328.